Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ARCK

Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis

Arbor Rapha Capital Bioholdings Corp. I logo

About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK)

Advanced Chart

Key Stats

Today's Range
$11.90
$11.90
50-Day Range
$10.42
$15.41
52-Week Range
$9.93
$15.59
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.

Receive ARCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter.

ARCK Stock News Headlines

DRGV Dragon Capital Group, Corp.
ECN Capital Corp. (ECNCF)
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
SuRo Capital Corp.
Ready Capital Corp.
Oxford Lane Capital Corp. (OXLC)
Deal Pro Capital Corporation (DPCC-P.V)
Quad 7 Capital
See More Headlines

ARCK Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), Abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI).

Company Calendar

Today
5/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARCK
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ARCK) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners